PT San Prima Sejati (Indonesia)

San Prima Sejati is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1998. San Prima Sejati is a prominent player in the Indonesian pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility and quality in Indonesia. The primary business line of San Prima Sejati is the production of generic and branded pharmaceuticals, catering to various therapeutic areas such as cardiovascular, anti-infectives, and central nervous system disorders. The company also engages in secondary activities, including the distribution of medical devices and health supplements. San Prima Sejati operates several branches across Indonesia, ensuring a robust local geographical footprint that allows it to effectively serve healthcare providers and patients nationwide. The company has established a strong presence in key cities, enhancing its distribution network and customer reach. In terms of global operations, San Prima Sejati has begun exploring export markets in Southeast Asia, aiming to expand its footprint beyond Indonesia. The company is actively seeking partnerships and joint ventures with international pharmaceutical firms to enhance its product offerings and technological capabilities. San Prima Sejati is a member of several industry associations, including the Indonesian Pharmaceutical Association, which helps it stay abreast of industry trends and regulatory changes. The company is committed to innovation and quality, with a vision to become a leading pharmaceutical company in the region, dedicated to improving health outcomes through affordable and effective healthcare solutions.